Crisaborole Inhibits Itch and Pain by Preventing Neutrophil Infiltration in a Mouse Model of Atopic Dermatitis

• Autores principales: Darya Pavlenko (Autor), Zeynep Todurga Seven (Autor), Lauren Bystrom (Autor), Anika Markan (Autor), Rebecca Verpile (Autor), Hirotake Ishida (Autor), Tasuku Akiyama (Autor)
• Formato: Libro
• Publicado: Medical Journals Sweden, 2023-08-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Crisaborole, a phosphodiesterase 4 (PDE4) inhibitor, has been approved for the treatment of mild to moderate atopic dermatitis. Atopic dermatitis is often associated with increased pain. Using a mouse model, this study investigated whether crisaborole suppresses pain associated with atopic dermatiti...